AI assistant
Sending…
BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2015
Jul 17, 2015
31868_dirs_2015-07-17_ea00b26f-a4ef-497c-8ce1-4d81b85a6402.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2015-07-15
Reporting Person: Stonehouse Jon P (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-07-15 | Common Stock | M | 33868 | $11.81 | Acquired | 684737 | Direct |
| 2015-07-15 | Common Stock | F | 25526 | $15.67 | Disposed | 659211 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-07-15 | Emp. Stock Option (Right to Buy) | $11.81 | M | 33868 | Disposed | 2017-01-05 | Common Stock (33868) | Direct |
More from BIOCRYST PHARMACEUTICALS INC
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 4
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 24
Regulatory Filings
2026
Mar 20